CA

Roseline Therrien

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roseline Therrien: Innovator in Women's Health Diagnostics

Introduction

Roseline Therrien is a prominent inventor based in California, known for her significant contributions to women's health diagnostics. With a total of two patents to her name, she has made strides in the detection of common vaginal infections, enhancing the accuracy and efficiency of diagnostic methods.

Latest Patents

Therrien's latest patents focus on the multiplex detection of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. These patents disclose methods and compositions for detecting these conditions, utilizing multiplex nucleic acid-based testing methods. In her innovations, the presence or absence of VVC-associated and a plurality of BV-related bacteria in a sample can be determined, which is crucial for effective treatment and management.

Career Highlights

Roseline Therrien is currently associated with Becton Dickinson and Company Limited, where she continues to work on advancing diagnostic technologies. Her expertise in the field has positioned her as a key player in developing innovative solutions for women's health.

Collaborations

Therrien collaborates with notable colleagues, including Nancy Paquette and Marie-Helene Tremblay, who contribute to her research and development efforts. Their teamwork fosters an environment of innovation and shared knowledge, further enhancing the impact of their work.

Conclusion

Roseline Therrien's contributions to women's health diagnostics through her patents and collaborations highlight her role as an influential inventor in the field. Her work not only advances medical technology but also improves the quality of care for women facing these health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…